Williams, David W.

Candida glabrata, Candida parapsilosis and Candida tropicalis : biology, epidemiology, pathogenicity and antifungal resistance

Silva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2012) · FEMS Microbiology Reviews

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 969

Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition

Silva, S., Henriques, M., Martins, A., Oliveira, R., Williams, D., & Azeredo, J. (2009) · Medical Mycology

Antifungal resistance and susceptibilityBacterial biofilms and quorum sensing

Cited by 390

Adherence and biofilm formation of non-Candida albicans Candida species

Silva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2011) · Trends in Microbiology

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 304

Nitrate-responsive oral microbiome modulates nitric oxide homeostasis and blood pressure in humans

Vanhatalo, A., Blackwell, J. R., L’Heureux, J. E., Williams, D. W., Smith, A., van der Giezen, M., Winyard, P. G., Kelly, J., & Jones, A. M. (2018) · Free Radical Biology and Medicine

Oral microbiology and periodontitis researchGut microbiota and health

Cited by 256

Candida glabrata and Candida albicans co‐infection of an in vitro oral epithelium

Silva, S., Henriques, M., Hayes, A., Oliveira, R., Azeredo, J., & Williams, D. W. (2011) · Journal of Oral Pathology & Medicine

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 108

The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic

Silva, S., Pires, P., Monteiro, D. R., Negri, M., Gorup, L. F., Camargo, E. R., Barbosa, D. B., Oliveira, R., Williams, D. W., Henriques, M., et al. (2013) · Medical Mycology

Antifungal resistance and susceptibilityDental materials and restorations

Cited by 101

Atomoxetine versus Methylphenidate in Paediatric Outpatients with Attention Deficit Hyperactivity Disorder: A Randomized, Double-Blind Comparison Trial

Wang, Y., Zheng, Y., Du, Y., Song, D. H., Shin, Y.-J., Cho, S. C., Kim, B. N., Ahn, D. H., Marquez-Caraveo, M. E., Gao, H., et al. (2007) · Australian & New Zealand Journal of Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 84

Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder

Bangs, M. E., Hazell, P., Danckaerts, M., Hoare, P., Coghill, D. R., Wehmeier, P. M., Williams, D. W., Moore, R. J., Levine, L., & for the Atomoxetine ADHD/ODD Study Group (2008) · Pediatrics

Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development

Cited by 79

Effect of Atomoxetine on Executive Function Impairments in Adults With ADHD

Brown, T. E., Holdnack, J., Saylor, K., Adler, L., Spencer, T., Williams, D. W., Padival, A. K., Schuh, K., Trzepacz, P. T., & Kelsey, D. (2011) · Journal of Attention Disorders

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 59

Atomoxetine Improved Attention in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Dyslexia in a 16 Week, Acute, Randomized, Double-Blind Trial

Wietecha, L., Williams, D., Shaywitz, S., Shaywitz, B., Hooper, S. R., Wigal, S. B., Dunn, D., & McBurnett, K. (2013) · Journal of Child and Adolescent Psychopharmacology

Attention Deficit Hyperactivity DisorderDevelopmental and Educational Neuropsychology

Cited by 58

Tachyphylaxis after Repeated Antidepressant Drug Exposure in Patients with Recurrent Major Depressive Disorder

Amsterdam, J. D., Williams, D., Michelson, D., Adler, L. A., Dunner, D. L., Nierenberg, A. A., Reimherr, F. W., & Schatzberg, A. F. (2009) · Neuropsychobiology

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 39

Atomoxetine Effects on Executive Function as Measured by the BRIEF-A in Young Adults with ADHD: A Randomized, Double-Blind, Placebo-Controlled Study

Adler, L. A., Clemow, D. B., Williams, D. W., & Durell, T. M. (2014) · PLoS ONE

Attention Deficit Hyperactivity DisorderDevelopmental and Educational Neuropsychology

Cited by 32

Atomoxetine-related change in sluggish cognitive tempo is partially independent of change in attention-deficit/hyperactivity disorder inattentive symptoms

McBurnett, K., Clemow, D., Williams, D., Villodas, M., Wietecha, L., & Barkley, R. (2017) · Journal of Child and Adolescent Psychopharmacology

Attention Deficit Hyperactivity DisorderDevelopmental and Educational Neuropsychology

Cited by 25

Atomoxetine Treatment in Adolescents with Attention-Deficit/Hyperactivity Disorder

Wietecha, L. A., Williams, D. W., Herbert, M., Melmed, R. D., Greenbaum, M., & Schuh, K. (2009) · Journal of Child and Adolescent Psychopharmacology

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 21

Reading Outcomes of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Dyslexia Following Atomoxetine Treatment

Shaywitz, B. A., Williams, D. W., Fox, B. K., & Wietecha, L. A. (2014) · Journal of Child and Adolescent Psychopharmacology

Attention Deficit Hyperactivity DisorderReading and Literacy Development

Cited by 18

Ageing modifies the oral microbiome, nitric oxide bioavailability and vascular responses to dietary nitrate supplementation

Vanhatalo, A., L'Heureux, J. E., Black, M. I., Blackwell, J. R., Aizawa, K., Thompson, C., Williams, D. W., van der Giezen, M., Winyard, P. G., & Jones, A. M. (2025) · Free Radical Biology and Medicine

Oral microbiology and periodontitis researchCardiovascular Health and Disease Prevention

Cited by 15